Logiscreen

Jade Biosciences Inc

$19.70
Market Cap 971.53M
ROE -51.3%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 14.3
Revenue QoQ 0.0%
EPS QoQ -1.0%
F-Score 2

About

Aerovate Therapeutics is a biotechnology company that was focused on improving the lives of patients with rare cardiopulmonary disease.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-7.97
vs median 36.93
P/B
3.49
vs median 2.32
ROE
-0.51
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics